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Abstract   
Receptor activator of NF-B ligand (RANKL) and pro-inflammatory cytokines are 
believed to play important roles in osetoclastogenesis. We recently reported that 
the innate immune recognition receptor, toll-like receptor (TLR) 2 is crucial for 
inflammatory bone loss in response to Porphyromonas gingivalis, the primary 
organism associated with chronic inflammatory periodontal disease. However, 
the contribution of the TLRs of the macrophage in osteoclastogenesis has not 
been defined.  In this study we defined a requirement for TLR2 in tumor 
necrosis factor (TNF)- elicited osteoclastogenesis in response to exposure with 
P. gingivalis. Culture supernatant (CS) fluids from P. gingivalis-stimulated 
macrophages induced bone marrow macrophages-derived osteoclastogenesis. 
This activity was dependent on TNF- and occurred independent of RANKL, 
interleukin (IL) -1, and IL-6.  CS fluids from P. gingivalis-stimulated TLR2-/- 
macrophages failed to express TNF- and these fluids induced significantly less 
osteoclast formation as compared with wild type or TLR4-/- macrophages. In 
addition, P. gingivalis-induced the up-regulation of cell surface expression of 
TLR2 on macrophages, which was demonstrated to functionally react to 
re-exposure with P. gingivalis as measured by a further increase in TNF- 
production. These results demonstrate that macrophage-dependent TLR2 
signaling is crucial for TNF--dependent / RANKL-independent 
osteoclastogenesis in response to P. gingivalis. Furthermore, the ability of P. 
gingivalis to induced cell surface expression of TLR2 may contribute to the 
chronic inflammatory state induced by this pathogen. 
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Introduction 
Bone metabolism is a complex process, and in healthy individuals, a 
homeostatic balance is achieved between bone resorption and new bone 
formation (7).  Osteoclasts play an important role in bone resorption and 
originate from the fusion of precursors belonging to the monocyte/macrophage 
lineage.  Receptor activator of nuclear factor B ligand (RANKL), a member of 
the tumor necrosis factor (TNF) ligand super family, is a major factor involved in 
osteoclast generation.  Both soluble and transmembrane forms of RANKL 
induce osteoclast formation when these cells are cultured with macrophage 
colony- stimulating factor (M-CSF) (16).  RANKL-induced osteoclast formation 
is inhibited by osteoprotegerin (OPG), a decoy receptor of RANKL (31, 38).  
Osteoclast differentiation also occurs through a mechanism that is independent 
of RANKL-RANK interaction and is dependent on TNF- (3, 20).  It has been 
reported that TNF- dependent osteoclastogenesis occurs when permissive 
levels of RANKL exist (22). Recently, however, Kim et al. (19) reported that 
transforming growth factor (TGF)- treated bone marrow (BM) macrophages 
could be differentiated into osteoclast-like cells when cultured with TNF- by a 
mechanism that was independent of RANKL-RANK suggesting that TNF- also 
plays an important role in osteoclastogenesis. 
In chronic inflammatory bone diseases including rheumatoid arthritis (RA), 
RANKL as well as pro-inflammatory cytokines such as TNF-, interleukin (IL)-1 
and IL-6 have been shown to be important for disease progression (14).  
Histological evaluations have revealed that the cellular composition of 
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inflammatory bone lesions in RA primarily consists of T and B cells, as well as 
macrophages (27, 32).  T cells and B cells have been reported to contribute to 
the acceleration of bone resorption by production of cytokines and RANKL (12, 
21, 37).  Macrophages in inflamed tissues can not only differentiate to 
osteoclasts (1), but also appear to accelerate bone resorption through 
production of pro-inflammatory cytokines (8).  
Toll-like receptors (TLRs) are a group of pathogen-associated pattern 
recognition receptors, which have been identified as key participants in innate 
recognition for pathogens (23, 33).  TLR2 is activated by bacterial lipoproteins, 
peptidoglycans, and Staphylococcus aureus lipoteichoic acid (SLTA) (2, 29, 30).  
TLR4 recognizes enteric lipopolysaccharide (LPS) (34).  Monocytes and 
macrophages express both TLR2 and TLR4 (15).  Following TLR engagement 
macrophages produce pro-inflammatory cytokines such as IL-1, IL-6 and 
TNF- (17, 18, 29).  A recent study reported that peripheral blood mononuclear 
cells of RA patients expressed increased TLR2 and TLR4 when compared to 
levels expressed in cells obtained from healthy subjects (28).  Iwahashi et al. 
(18) have also shown that both blood monocytes and synovial tissue 
macrophages in RA patients expressed high levels of TLR2.  While these 
studies have correlated macrophage TLR expression with inflammatory tissue 
damage associated with bone destruction, a requirement for 
macrophage-specific TLR signaling influencing osteoclast formation has not 
been defined.  
   Periodontal disease is a well characterized chronic inflammatory bone 
destructive disease induced by bacterial infection.  While periodontal disease 
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and RA are different diseases initiated by distinct causes, it has been suggested 
that similar pathological process are involved in the resulting inflammatory bone 
destruction (14).  Histological analysis of local inflammatory lesions obtained 
from severe periodontal disease patients possess increased expression of TLR2 
and TLR4 from macrophages as compared to lesions obtained from patients 
with mild periodontal disease (25).  Others, on the other hand, have reported 
there is significant down-regulation of TLR2 mRNA by real-time PCR in chronic 
periodontitis (26).  We and others (6, 11) have reported that TLR2 is crucial for 
inflammatory bone loss in response to the Gram-negative pathogen 
Porphyromonas gingivalis (P. gingivalis), the primary organism associated with 
chronic inflammatory periodontal disease. However, the contribution of the 
innate immune recognition system of the macrophage in inflammatory bone loss 
has not been defined.  In this study, we examined the requirement for TLR2 and 
TLR4 in P. gingivalis infected macrophage induced osteoclastogenesis.  Using 
murine macrophages, we detail a mechanism by which TLR2-mediated signaling 
to P. gingivalis stimulates a potent soluble pro-inflammatory response which 
stimulates bone marrow macrophage (BMM) to undergo osteoclastogenesis via 
TNF- induction. Furthermore we demonstrate that P. gingivalis-induced the 
up-regulation of cell surface expression of TLR2 on macrophages, which was 
demonstrated to functionally react to re-infection with P. gingivalis as measured 
by a further increase in TNF- production. The ability of P. gingivalis to induce 
cell surface expression of TLR2 may further contribute to chronic inflammation, 
which is characteristic of human periodontal disease.  
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MATERIALS AND METHODS 
Animals 
C57BL/6 wild-type (WT) (Jackson Laboratory, Bar Harbor, Me), TLR2-knochout 
(TLR2-/-) and TLR4-knochout (TLR4-/-) mice (originally provided by S. Akira, 
Osaka University) were cared for in accordance with Boston University 
Institutional Animal Care and Use Committee procedures.  
 
Bacteria and growth conditions 
P. gingivalis strain 381 was grown on anaerobic blood agar plates (BBL media; 
Becton Dickinson Co.) and used to seed Brain Heart Infusion broth (BHI; Difco) 
(pH 7.4) supplemented with yeast extract (Difco), hemin (1g /ml; Sigma) and 
menadione (1 g/ml; Sigma).  Organism numbers were standardized using a 
spectrophotometer (DU 7500, Beckman) at an optical density of 1 at 660 nm 
(equivalent to 1x109 CFU/ml). 
 
Peritoneal macrophage cultures  
Male mice (8-10 wk of age) were injected intraperitoneally with 3.0 ml of a sterile 
thioglycollate solution (Remel).  After 4 days, peritoneal exudates cells were 
harvested by lavage with RPMI 1640 medium (Gibco) containing 10% fetal 
bovine serum (FBS) (Gibco) and 50 g/ml of gentamicin (Sigma).  After the 
cells were cultured in plate dish for 24 h, non-adherent cells were removed.  
The adherent cells were cultured with medium not containing antibiotics for one 
day and were used as peritoneal macrophages.  
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Macrophage P. gingivalis stimulation assays 
Peritoneal macrophages from WT, TLR2-/-, or TLR4-/- mice were cultured with P. 
gingivalis at a various multiplicity of infection (MOI) for 6 or 24 hours in 12- (for 
FACS or osteoclast formation) or 96- (for ELISA) well plate dishes.  In some 
experiments, cells were stimulated with 2 g/ml of Staphylococcus aureus 
lipoteichoic acid (SLTA) (InvivoGen) or 100ng/ml of Escherichia. Coli (E. coli) 
LPS (InvivoGen).  Some wells were incubated with either 20 g/ml of murine 
TLR2 blocking antibody (T2.5) or isotype-matched rat IgG (eBioscience) before 
stimulation of cells.  Cells were collected for FACS analysis. The culture 
supernatant (CS) fluids centrifuged to eliminate the bacteria were collected and 
keep in –70C until used for ELISA or osteoclast formation. Unstimulated 
macrophages were used as a control. 
 
TLR functional assay 
Peritoneal macrophages were cultured with P. gingivalis (MOI = 10) in 96-well 
culture plates for 1 h.  Non-adherent bacteria were then removed by washing, 
and these cells were cultured with medium for 5 hrs.  After medium change, 
these P. gingivalis infected cells were re-exposed with P. gingivalis (MOI = 10) for 
an additional 24 hrs. CS fluids and cells were collected for ELISA or FACS 
analysis as described below. 
  
Cytokines and RANKL assay   
Concentrations of IL-1, IL-6, TNF- (BD Biosciences), and RANKL (R&D 
system) in CS fluids were determined using commercially available murine 
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enzyme-linked immunosorbent assay (ELISA) kits.  
 
Flow cytometry analysis 
Fluorescence-activated cell sorter (FACS) analysis was performed on 
macrophage cultures by first washing cells in buffer (0.2%BSA/PBS), followed 
by incubation with Fc receptor blocker (eBioscience). The cells were then 
labeled with fluoescein isothiocyanate (FITC) conjugated anti-mouse TLR2 
monoclonal antibody (mAb) (6C2, eBioscience), phycoerythrin (PE)-conjugated 
anti-mouse TLR4 mAb (MTS510, eBioscience), PE-conjugated anti-mouse 
RANKL mAb (IK22/5, eBioscience) or isotype controls.  The cells were washed 
and 10,000 events were analyzed by flow cytometry using a FACScan 
flowcytometer (Becton Dickinson). Geometric means of three independent 
experiments were utilized for statistical analysis. 
 
Osteoclast formation  
C57BL/6 mouse BM cells were cultured in -minimum essential medium 
(-MEM) (Gibco) containing 10% FBS, 100 g/ml of streptomycin, 100 IU of 
penicillin (Cellgro) and 5ng/ml of mouse recombinant M-CSF (R&D Systems) for 
12h in 100-mm diameter dishes.  Non-adherent cells were harvested and 
cultured with 30ng/ml of M-CSF in 100-mm diameter dishes for an additional 24 
hours.  Non-adherent cells were washed out and adherent cells were collected 
and used as BMMs (3).  BMMs (3x104 cells/0.5ml/well) were cultured for 5 days 
in -MEM containing 10% FBS, antibiotics, 30ng/ml of M-CSF and 0.2 ml of CS 
fluids from macrophages of WT, TLR2-/- or TLR4-/- mice challenged with P. 
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gingivalis (MOI = 10) for 24 hours in 8-well Lab-Tek chamber slide (Nalge Nunc 
international).  To some wells were added 300ng/ml of OPG, or 5 g/ml of 
anti-mouse TNF- IL-1 IL-6 polyclonal antibody, or normal goat IgG 
(R&D system).  On day 3, the culture medium and all reagents were replaced.  
To identify osteoclasts, cells were fixed in 4% paraformaldehyde and stained 
with tartrate-resistant acid phosphatase (TRAP) (Sigma).  TRAP-positive 
multi-nucleated cells (more than three unstained nuclei) were defined as 
osteoclast, and the number was determined by microscopic counts. 
 
Pit formation assay 
BMMs (2 x 104 cells/0.25ml/ well) were plated on dentine disks (OsteoSite) in 
96-well culture dishes and cultured in -MEM containing 10% FBS, antibiotics 
and 100 l of CS fluids from peritoneal macrophages of WT, TLR2-/- or TLR4-/- 
mice infected with P. gingivalis in the presence of M-CSF (30ng/ml) for 7 days.  
Medium and all reagents were replaced every 3 days. After culturing, the dentine 
disks were cleaned by ultrasonication in 1M of NH4OH to remove adherent cells. 
After rinsing, dentine disks were stained with hematoxylin for visualizing 
resorption lacunae (20).  
 
Statistical analysis 
Statistical analysis was carried out with Statview software (SAS Institute Inc.).  
Unpaired t-test, one- or two-factor analysis of variance (ANOVA) with 
Tukey-Kramer test was performed to assess differences among groups. p<0.05 




P. gingivalis infected macrophages produce the pro-inflammatory 
cytokines TNF-, IL-1, and IL-6, but not RANKL 
While a few studies have examined the pro-inflammatory response of 
mouse macrophages to P. gingivalis, little is known about the expression of 
pro-inflammatory cytokines believed to play a role in osteoclastogenesis 
following exposure with live P. gingivalis.  Thus in our initial studies we 
examined the production of TNF-, IL-1, IL-6 and soluble RANKL in CS-fluids 
from peritoneal macrophages of WT mice in response to live P. gingivalis at 
different MOI.  There is the possibility that some enzyme from P. gingivalis can 
affect the activities of cytokines in culture medium. In our present study, we 
focused the affect live bacteria with some enzyme but not only their components, 
because a lot of components of bacteria will influence in vivo. To examine the 
affect of live bacteria, we use the medium from un-stimulated macrophage as 
control. Significantly elevated levels of TNF-, IL-1, and IL-6 were detected 24 
hours post-exposure with P. gingivalis at MOIs of 10 and 100 (Fig. 1A-C); 
however, RANKL production was not increased when macrophages were 
cultured with P. gingivalis (Fig. 1D).  We also examined challenged 
macrophages for membrane bound RANKL expression by FACS.  The 
expression of membrane RANKL was similar between challenged and 
unchallenged macrophages (data no shown).  Since it has been reported that 
TGF- can influence osteoclastogenesis [8], we also measured TGF- levels in 
CS-fluids. TGF- levels in CS-fluids from live P. gingivalis stimulated cells were 
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not significantly different from unstimulated cells (p>0.05; data not shown).  
These results indicate that macrophages cultured with P. gingivalis express 
pro-inflammatory cytokines but do not produce soluble or membrane-bound 
RANKL. 
 
TLR2 partially mediates TNF-, production by murine macrophages in 
response to P. gingivalis. 
We and others (6, 11) recently reported that TLR2 is crucial for inflammatory 
bone loss in response to P. gingivalis in a mouse model of oral bone loss. To 
assess the requirements for TLR signaling pathways in pro-inflammatory 
cytokine production in response to P. gingivalis, we cultured macrophages from 
WT, TLR2-/- and TLR4-/- mice with live P. gingivalis and assessed the levels of 
each cytokine in CS-fluids.  Expectedly, macrophages from TLR2-/- and TLR4-/- 
mice did not produce cytokines in response to their cognate ligands (SLTA and E. 
coli LPS, respectively), while macrophages obtained from WT mice responded 
well to stimulation with both antigens (Fig. 2A-C). TNF- production by TLR2-/- 
mouse macrophages cultured with P. gingivalis was clearly reduced when 
compared to WT or TLR4-/- mice (Fig. 2A). IL-1ß and IL-6 production were similar 
among all strains of mouse macrophages cultured with P. gingivalis (Fig. 2B, 2C). 
To verify the requirement for TLR2 in eliciting pro-inflammatory cytokines from 
macrophages in response to P. gingivalis, we incubated WT macrophages with 
anti-mouse TLR2 blocking antibody followed by exposure with P. gingivalis. We 
observed that blocking antibody treatment inhibited SLTA-induced cytokine 
production, but failed to inhibit stimulation of macrophages cultured with E. coli 
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LPS. Macrophages cultured with P. gingivalis, after anti-TLR2 antibody, 
demonstrated a marked reduction in TNF- production, but showed no changes 
in IL-1 and IL-6 levels (Fig. 2D-F).  Collectively, these results indicate that the 
TLR2 signaling is involved in mediating the TNF-, response to live P. gingivalis 
and that the observed IL-1 and IL-6 response are mediated via TLR2 
independent mechanisms.  
 
Live P. gingivalis stimulation sensitizes murine macrophages making them 
hyper-responsive to subsequent exposure 
We have previously reported that P. gingivalis infection results in the up 
regulation of cell surface TLRs on endothelial cells (39).  We postulated that the 
ability of P. gingivalis to stimulate cell surface expression of TLRs on the 
endothelial cell could serve as a mechanism to sensitize these cells to other 
TLRs ligands and could play a role in chronic inflammation induced by this 
pathogen.  To determine if a similar response occurred in macrophages, we 
cultured peritoneal macrophages with P. gingivalis and examined the temporal 
expression of TLR2 and TLR4.  As shown in Figure 4, macrophages in 
response with P. gingivalis expressed increased cell surface TLR2 as compared 
to un-stimulated macrophage cultures at both 6 and 24 hours post-stimulation.  
However, we did not observe changes in TLR4 surface expression following 
incubation of macrophages with P. gingivalis at either time point (Fig. 3A). 
   We next examined if the increased expression of TLR2 on the surface of 
macrophages elicited by P. gingivalis could enhance TNF- production to 
subsequent exposure of macrophages to this organism.  We confirmed that 
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TLR2 but not TLR4 expression was significantly up regulated before re-exposure 
(Fig. 3B).  Exposure of macrophages with P. gingivalis, prior to re-exposure with 
the organism, resulted in a significant increase in TNF- production as 
compared to macrophages which had not been exposed to P. gingivalis.  SLTA, 
TLR2 agonist, stimulation also increased TNF-, production when macrophages 
were exposed to P. gingivalis (Fig. 3C). Collectively these results indicate that 
similar to that observed in endothelial cells, live P. gingivalis exposure can 
induce cell surface expression of TLR2 which results in sensitization of the 
macrophage as measured by TNF- production following re-exposure with this 
organism.  
 
CS fluids collected from macrophages cultured with P. gingivalis induced 
osteoclast formation is mediated by TNF- but not RANKL.  
The differentiation of BMMs into osteoclasts has previously been 
demonstrated by RANKL or TNF-, in conjunction with M-CSF (3, 20).  To 
examine if CS fluids collected from peritoneal macrophages stimulated with P. 
gingivalis could induce osteoclast formation from BMMs, we stimulated BMMs 
with CS fluids from WT mouse peritoneal macrophages in response with P. 
gingivalis for 24 hours.  As shown in Figure 5, formation of osteoclast-like cells 
was induced by the CS fluids from P. gingivalis challenged macrophages, but not 
by unchallenged macrophages. TNF- blocking antibody, but not OPG or control 
goat IgG, completely blocked osteoclastogenesis induced by the CS fluids from 
peritoneal macrophages cultured with P. gingivalis (Fig. 4A and 5B).  We 
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confirmed that OPG or anti-TNF- antibody completely blocked the osteoclast 
formation in response to their cognate ligands (RANKL or TNF-, respectively) 
(p<0.0001, data not shown). In addition, we demonstrated that neither IL-1 nor 
IL-6, in conjunction with M-CSF, could induce osteoclast formation from BMMs 
(p=0.9955 or p=0.9991, respectively, data not shown).  We also attempted to 
block osteoclastogenesis using anti-mouse IL-1 or anti-mouse IL-6 blocking 
antibodies; however, these did not alter osteoclastogenesis elicited by CS fluids 
collected from P. gingivalis challenged macrophages (p=0.3152 or p=0.1783, 
respectively, data not shown).  These results indicate that osteoclast-like cell 
formation is dependent upon TNF-, but not IL-1, IL-6 or soluble RANKL that 
was present in the CS fluids collected from WT macrophages cultured with P. 
gingivalis. 
We next assessed the functional activity of osteoclast-like cells to resorb 
dentine.  CS fluids of macrophages in response to P. gingivalis, but not un 
stimulated cells also induced dentine resorption. Resorption of dentine by 
osteoclast-like cells elicited using CS fluids collected from macrophages cultured 
with P. gingivalis was completely blocked by anti-TNF- antibody, but not with 
OPG or control goat IgG (Fig. 4C).  Taken together these results indicate that 
the CS fluids from live P. gingivalis stimulsted peritoneal macrophages can 
promote functional osteoclast formation from BMMs.  
 
Role for TLR2 in osteoclast formation induction by CS fluids from 
macrophages in response to P. gingivalis. 
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To define the role of TLRs in macrophage cultured with P. gingivalis induced 
osteoclast formation, we next compared the ability of P. gingivalis stimulated WT, 
TLR2-/-, TLR4-/- peritoneal macrophages to induce osteoclastogenesis in vitro.  
CS fluids from live P. gingivalis stimulated macrophages were able to induce 
osteoclast formation in all mouse strains examined; however, CS fluids obtained 
from TLR2-/- macrophages induced the differentiation of much fewer osteoclasts 
when compared to CS fluids obtained from WT or TLR4-/- P. gingivalis stimulated 
macrophages (Fig 5. A and B).  As expected, TNF- levels in CS fluids 
obtained from P. gingivalis stimulated TLR2-/- macrophages were lower (1.9 ± 
0.8ng/ml) than that observed in CS fluids obtained from P. gingivalis infected WT 
(17.4 ± 2.5ng/ml) and TLR4-/- macrophages (17.5 ± 8.0ng/ml).  These results 
indicate that the reduced formation of osteoclasts following incubation with CS 
fluids from TLR2-/- macrophages appears to result from low levels of TNF- 
production.  We also observed that anti-TNF- blocking antibody, but not OPG 
and control goat IgG, added to the infected CS fluids, completely inhibited 
osteoclast-like cell formation in all mouse strains tested further confirming the 
importance of TNF- in mediating osteoclast formation by CS fluids obtained P. 
gingivalis stimulated macrophage. (Fig. 5B). 
 Resorption lacunae on the dentine were rarely observed with cells cultured 
with CS fluids from P. gingivalis stimulated macrophages obtained from TLR2-/- 
mice.  Conversely, dentine resorption induced by CS fluids from P. gingivalis 
stimulated macrophages from TLR4-/- mice was similar to that observed in the 
CS-fluids from WT mice macrophages (Fig. 5C).  These results indicate that P. 
gingivalis stimulated macrophages obtained from TLR4-/- mice also can induce 
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functional osteoclast formation.  Collectively, these results indicate that TLR2 
signaling plays an important role in live P. gingivalis induced osteoclastogenesis.  
Furthermore, TLR4 signaling does not appear to be critical for 
osteoclastogenesis and pit formation elicited by BMMs stimulated with CS fluids 
from macrophages in response to P. gingivalis.    
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DISCUSSION 
In this study we have defined a requirement for TLR2 in TNF- elicited 
osteoclastogenesis in response to with live P. gingivalis.  Furthermore, we 
determined that osteoclastogenesis in response to P. gingivalis while dependent 
on TNF- was independent of RANKL, IL-1, and IL-6. In addition, we also 
demonstrate that P. gingivalis-induced the up-regulation of cell surface 
expression of TLR2 on macrophages, which was shown to functionally react to 
re-infection with P. gingivalis as measured by a further increase in TNF- 
production. The ability of P. gingivalis to induce cell surface expression of TLR2 
may thus contribute to the chronic inflammatory state induced by this pathogen. 
While several reports have documented that both T and B cells play an 
important role in inflammatory oral bone loss (4, 12, 21, 35), it is clear that 
macrophages are also important immune cells in the initial innate immune 
recognition of bacteria.  Our results demonstrate the contribution of the 
macrophage in response with P. gingivalis and the resulting induction of 
osteoclastogenesis.  Histological studies have reported that RANKL-bearing 
macrophages are present in diseased tissue obtained from patients with 
periodontal disease (9, 24).  However, very little is known about the 
macrophage production of RANKL in vitro.  One study demonstrated that low 
levels of RANKL could be detected in culture supernatants of unstimulated 
human macrophages differentiated from blood monocytes; however, the 
functional activity of RANKL was not examined (10).  In our study, we found that 
osteoclastogenesis and dentine pit formation induced by P. gingivalis stimulated 
macrophage CS fluids was not affected by OPG.  These results indicate that the 
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induction of osteoclastogenesis by CS fluids was independent of soluble RANKL.  
RANKL exists not only as soluble form but also as a membrane bound form and 
both membrane and soluble RANKL are capable of stimulating 
osteoclastogenesis.  However, we did not observe a difference in the 
expression of membrane bound RANKL on macrophages following stimulation 
with P. gingivalis.  Gingipain, systein protease, from P. gingivalis should be exist 
in culture medium and this may affect RANKL form and its activity. Even if 
RANKL from macrophage was degraded by gingipain, it is no doubt P. gingivalis 
stimulated-macrophage induced osteoclast formation in independent of RANKL 
because the formation could not be blocked with OPG. Collectively these results 
suggest that RANKL does not play an important role in osteoclast formation 
induced by live P. gingivalis-stimulated macrophages.   
TNF- has been previously reported to stimulate osteoclastogenesis by a 
RANKL-independent mechanism (3, 19, 20). Kim et al. (19) reported that TNF- 
was capable of mediated BMM osteoclastogenesis; however, TGF- was 
reported to also play a role in this process.  While we did detect low levels of 
TGF- in the fluids of unstimulated macrophages, we did not observe significant 
differences in TGF- production between unstimulated or P. gingivalis-stimulated 
macrophages. Since our BMMs were exposed to FBS prior to incubation with CS 
fluids and it is known that TGF- is present in FBS, we cannot definitively rule 
out a role for TGF- in P. gingivalis induced osteoclastogenesis in our 
macrophage system. 
TNF- is frequently detected in inflamed tissues from patients with 
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periodontal disease (36). TNF- has been demonstrated to contribute to oral 
bone loss in a P. gingivalis induced inflammatory oral bone loss mouse model 
(13).  P. gingivalis has also been demonstrated by others to induce TNF-  
following stimulation of monocyte/macrophage (5) and recent studies have 
documented a role for TLR2 in this response (40). Our results are in agreement 
with these studies and further demonstrated that TNF- production in response 
to P. gingivalis was independent of TLR4 signaling. Moreover, we also observed 
that both IL-1 and IL-6 production from P. gingivalis stimulated macrophages 
occurred via a TLR2-independent signaling mechanism. We and others recently 
reported that TLR2 deficient mice were resistant to inflammatory bone loss 
following oral infection with P. gingivalis (6. 11).  We also demonstrated that 
TLR4 is not absolutely required for P. gingivalis induced oral inflammatory bone 
loss (11). Thus it appears that TLR2 is an essential signaling receptor for P. 
gingivalis as demonstrated in both in vitro and in vivo models of inflammation. 
Another important observation in this study was that live P. gingivalis 
induced the up-regulation of TLR2 surface expression on macrophages. 
Furthermore, we demonstrated that macrophages, which were exposed to P. 
gingivalis, responded upon subsequent exposure with P. gingivalis or SLTA as 
measured by an increase in TNF- production. Muthukuru et al have reported 
that re-stimulation with P. gingivalis LPS induce down-regulation of TLR2 and 
TLR4 on human monocyte and reduction of cytokines secretion (26). In present 
study, we used live P. gingivalis but not their components for stimulation of 
murine macrophages. The effect of TLRs regulation of live P. gingivalis may be 
different from that of their each component.  Collectively these results indicate 
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that similar to that observed in endothelial cells, live P. gingivalis exposure can 
induce cell surface expression of TLR2 which results in sensitization of the 
macrophage as measured by TNF- production following re-exposure with this 
organism. The ability of P. gingivalis to induce cell surface expression of TLR2 
may contribute to the chronic inflammatory state induced by this pathogen. Many 
chronic infectious diseases such as periodontal disease induced by various 
bacterial infections, therefore, other bacteria may also act similar to P. gingivalis. 
In conclusion we have demonstrated the importance of TLR2 signaling in 
macrophage-induced osteoclastogenesis following live bacterial stimulation in 
vitro.   Furthermore we observed that this response is mediated via TNF-. In 
addition, we have confirmed that P. gingivalis stimulation can induce cell surface 
expression of TLR2, which results in sensitization of the macrophage as 
measured by TNF- production.  It is tempting to speculate that chronic 
inflammation in response to P. gingivalis infection of the macrophage results 
from the increased expression of TLR2 which in turn leads to increased 
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FIGURE 1.  Comparison of pro-inflammatory cytokines and RANKL 
production from peritoneal macrophages cultured with P. gingivalis.  
Peritoneal macrophages from WT mice were cultured with P. gingivalis at the 
indicated MOIs for 6 or 24hours. CS fluids were then harvested for ELISA of 
TNF- (A), IL-1 (B), IL-6 (C) and RANKL (D).  Control cultures were incubated 
with culture medium alone (unstimulated).  Data are shown as the mean and 
SDs of two independent experiments each performed in triplicate. * = p<0.05, ** 
= p<0.01 compared with uninfected controls at each time points.  ND = not 
detectable. 
 
FIGURE 2.  P. gingivalis induces TNF- production in macrophages via a 
TLR2 dependent pathway.  Peritoneal macrophages from WT, TLR2-/- and 
TLR4-/- mice were cultured with P. gingivalis (MOI = 10) (P.g.) for 24hours (A-C).  
In another experiment, peritoneal macrophages from WT mice were pre-treated 
with anti-TLR2 blocking antibody, isotype control Ab for 1 hour or untreated 
followed by culture with P. gingivalis (MOI = 10) (P.g.) for 24hours (D-F).  Cells 
were also stimulated with SLTA (2 g/ml) (SLTA) or E. coli LPS (100 ng/ml) (E.c. 
LPS) as a control.  CS fluids were harvested for ELISA analysis of TNF-. (A, 
D), IL-1 (B, E), or IL-6 (C, F).  Control cultures were incubated with culture 
media only (unstimulated).  Data are shown as the mean and SDs of two 
independent experiments each performed in triplicate.  * = p<0.01 compared 
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with each of the WT macrophages. †= p<0.01 compared with P.g. of TLR4-/- 
macrophages. ** = p<0.01 compared with each of the isotype control. 
 
FIGURE 3.  P. gingivalis up-regulates TLR2 surface expression on murine 
macrophages.  (A) Peritoneal macrophages from WT mice were cultured with 
P. gingivalis (MOI = 10) or with medium alone (uninfected) and temporal 
expression of TLR2 and TLR4 were determined by FACS analysis at 6 and 24 
hours.  Data is expressed as the geo-mean fluorescence intensity and SDs of 3 
independent experiments.  * = p<0.01 by unpaired t-test.  (B) Peritoneal 
macrophages from wild-type mice were cultured with P. gingivalis (MOI = 10) or 
with medium alone for 1 hour, and then non-adherent bacteria were removed by 
washing out cells.  The cells were then incubated with medium alone for 5 
hours and the temporal expression of TLR2 and TLR4 were determined by 
FACS analysis. Data is expressed as the geo-mean fluorescence intensity and 
SDs of 3 independent experiments.  * = P<0.01 by unpaired t-test. (C) 
Non-pre-exposed peritoneal macrophages or macrophages pre-exposed with P. 
gingivalis (MOI = 10) for 1hour, were washed and incubated with medium alone 
for 5 hours. Following medium change, cells were then incubated with medium, 
P. gingivalis (MOI = 10) or SLTA (2g/ml) for 24 hours and TNF- production in 
the CS fluids was assessed by ELISA.  Data are shown as the mean and SDs 
of two independent experiments each performed in triplicate.  * = p<0.01 by 
unpaired t-test. 
 
FIGURE 4.  CS fluids of P. gingivalis infected peritoneal macrophages 
 32
induce osteoclastogenesis. (A) Osteoclast formation. BMMs from WT mice 
were cultured with CS fluids from peritoneal macrophages that were previously 
infected with P. gingivalis (P.g.CS fluids) or CS fluids from uninfected 
macrophages (control CS fluids).  Some CS fluids were supplemented with 
OPG (300ng/ml) or anti-TNF- blocking antibody (5 g/ml) or control goat IgG (5 
g/ml) as indicated in each panel.  After 5 days of culture, cells were stained 
with TRAP for identification of osteoclasts.  Each representative photograph is 
shown. Bars = 100 m.  (B) Osteoclast numbers in cell cultures.   BMMs were 
cultured under the same conditions as described above. TRAP positive 
multinucleated cells were identified and counted.  Data are shown as the mean 
and SDs of two independent experiments each performed in triplicate.  * = 
p<0.01 compared with control CS fluids.  (C) Pit formation assay. BMMs were 
cultured on dentine disks under the same conditions as described above.  After 
7 days, cells were removed and the dentine disks were stained with hematoxylin.  
Representative photograph of duplicate is shown. Bars = 400 m.  All cultures 
(A-C) were incubated in the presence of M-CSF (30ng/ml).  Every 3 days, the 
medium and reagents were replaced. 
 
FIGURE 5.  Osteoclastogenesis induced by CS fluids of P. gingivalis 
infected peritoneal macrophages from TLR2-/- and TLR4-/- mice.  (A) 
Osteoclast formation. BMMs from WT mice were cultured with CS fluids from 
peritoneal macrophages obtained from WT, TLR2-/- and TLR4-/- mice that were 
previously infected with P. gingivalis (P.g. CS fluids), or uninfected macrophages 
(control CS fluids).  After 5 days of culture, cells were stained with TRAP. Each 
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representative photograph is shown.  Bars = 100 m.  (B) Osteoclast numbers. 
BMMs were cultured under the same conditions as described above.  Some 
macrophages were also cultured in the presence of OPG (300ng/ml), anti-TNF- 
blocking antibody (5g/ml) or control goat IgG (5g/ml).  TRAP positive 
multinucleated cells were counted in each well.  Data are shown as the mean 
and SDs of two independent experiments each performed in triplicate.  * = 
p<0.01 compared with P.g. CS fluids each mouse group.  ** = p<0.01 compared 
with P.g. CS fluids of WT.  †= p<0.01 compared with P.g. CS fluids of TLR4-/-.  
(C) Pit formation assay.  BMMs were cultured on dentine disks under the same 
conditions as described above.  After 7 days, cells were removed and the 
dentine disks were stained with hematoxylin.  Representative photograph of 
duplicate is shown.  Bars = 400 m.  All cultures (A-C) were incubated in the 
presence of M-CSF.  Every 3 days, the medium and all reagents were replaced. 
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